P3-094: An expanded access clinical program of erlotinib (Tarceva™) in patients with advanced stage IIIB/ IV non-small cell lung cancer
Journal of Thoracic Oncology（2007）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined